NO963559L - Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF) - Google Patents

Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF)

Info

Publication number
NO963559L
NO963559L NO963559A NO963559A NO963559L NO 963559 L NO963559 L NO 963559L NO 963559 A NO963559 A NO 963559A NO 963559 A NO963559 A NO 963559A NO 963559 L NO963559 L NO 963559L
Authority
NO
Norway
Prior art keywords
naurotrophic
bdnf
factor
derived
recombinant adenoviruses
Prior art date
Application number
NO963559A
Other languages
Norwegian (no)
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO963559L publication Critical patent/NO963559L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO963559A 1994-03-18 1996-08-26 Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF) NO963559L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.
PCT/FR1995/000250 WO1995025804A1 (en) 1994-03-18 1995-03-02 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)

Publications (1)

Publication Number Publication Date
NO963559L true NO963559L (en) 1996-08-26

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963559A NO963559L (en) 1994-03-18 1996-08-26 Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (en)
JP (1) JPH09510358A (en)
KR (1) KR970701784A (en)
AU (1) AU703793B2 (en)
CA (1) CA2184200A1 (en)
FI (1) FI963674A0 (en)
FR (1) FR2717496B1 (en)
IL (1) IL112992A0 (en)
MX (1) MX9603490A (en)
NO (1) NO963559L (en)
WO (1) WO1995025804A1 (en)
ZA (1) ZA952244B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
DE60137414D1 (en) * 2000-05-05 2009-03-05 Univ City COMPOSITIONS FOR STIMULATING REGENERATION AND RECONSTITUTION OF THE NERVOUS SYSTEM BY REGULATING THE ARGINASE 1 AND POLYAMINE SYNTHESIS
US20210079050A1 (en) * 2018-02-20 2021-03-18 Carmel Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755682A1 (en) * 1991-07-10 1997-01-29 Regeneron Pharmaceuticals, Inc. Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules
US5733871A (en) * 1991-11-08 1998-03-31 The General Hospital Corporation Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994003199A1 (en) * 1992-08-04 1994-02-17 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
ZA952244B (en) 1996-01-16
FI963674A (en) 1996-09-17
FR2717496B1 (en) 1996-04-12
AU1896295A (en) 1995-10-09
FI963674A0 (en) 1996-09-17
WO1995025804A1 (en) 1995-09-28
EP0750676A1 (en) 1997-01-02
MX9603490A (en) 1997-03-29
FR2717496A1 (en) 1995-09-22
IL112992A0 (en) 1995-06-29
JPH09510358A (en) 1997-10-21
AU703793B2 (en) 1999-04-01
CA2184200A1 (en) 1995-09-28
KR970701784A (en) 1997-04-12

Similar Documents

Publication Publication Date Title
IL116816A0 (en) Recombinant defective adenoviruses
DE69427370D1 (en) NEW INTEGRIN-BINDING PEPTIDES
DE69503375D1 (en) HIGH-RESOLUTION SUBTRACTIVE COLOR PROJECTION SYSTEM
FI924091A (en) AUTHORIZATION PROTOCOL SOM FOERSIKTIGHETSHJAELPMELEL
DE69519886D1 (en) Image decoder
DE69405225D1 (en) IMAGE COMPOSITION SYSTEM
GB2291308B (en) Error diffusion image encoding
DE69506832D1 (en) IMAGE PROJECTION SYSTEM
DE69736966D1 (en) LCD color projector
NO976058L (en) Recombinant Mistakine
FI953302A (en) New peptides
ATE480626T1 (en) NEW STREPTOGRAMINS
GB2338082B (en) Projector transporter
FI971499A0 (en) Novel peptides with immunomodulatory effects
DE69515791D1 (en) Color image projector
FI970168A (en) peptides
FI940109A (en) peptides
EP0690912A4 (en) Recombinant avian adenovirus vector
NO963559L (en) Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF)
DE69622119D1 (en) color projector
DE69714131D1 (en) LCD Projector
NO963907D0 (en) Recombinant adenoviruses encoding the neurotrophy factor of glial cells (GDNF)
FI950211A0 (en) Pore-forming peptides from Geolycosa riogrande
KR960027908U (en) Multi-screen projection
KR970056319U (en) LCD Projector

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application